We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PFGRUPSURA:BVCGrupo de Inversiones Suramericana SA Pfd Analysis

Data as of 2026-05-25 - not real-time

COP 40,600.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock trades at 40,600 COP, sitting below its 20‑day (40,888), 50‑day (41,758) and 200‑day (42,282) simple moving averages, signaling a short‑term bearish bias despite a modestly neutral RSI of 45. The MACD histogram is positive (+66) and the signal line turned bullish, suggesting a possible technical bottom forming, while volume is on an upward trend, adding weight to the reversal hypothesis. Volatility is elevated at roughly 40% over the past 30 days, but the beta of 0.49 indicates the share moves less than the broader market. 
Fundamentally, the company appears cheap on a value basis with a trailing P/E of 9.1 versus an industry average of 16.8 and a P/B of 0.68, yet the discounted cash‑flow model caps fair value near 23,074 COP, implying the market is pricing significant upside. Revenue is contracting (-10.8%) and operating margins are thin (2.3%), but cash generation remains strong and the dividend yield is an attractive 4.93% supported by a 33% payout ratio. Leverage is notable (debt‑to‑equity 55.5) and the firm faces moderate regulatory and geographic exposure across Latin America, which tempers the upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages indicating bearish pressure
  • Positive MACD histogram suggesting a possible technical bottom
  • High dividend yield provides income cushion despite overvaluation

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • DCF fair value far below current price signaling a likely correction
  • Revenue contraction and thin operating margins limit growth prospects
  • Elevated volatility and moderate leverage increase downside risk

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Attractive valuation multiples relative to industry peers
  • Sustainable dividend yield with a comfortable payout ratio
  • Diversified geographic footprint and low beta reduce market risk

Key Metrics & Analysis

Financial Health

Revenue Growth-10.80%
Profit Margin6.46%
P/E Ratio9.1
ROE8.96%
ROA2.93%
Debt/Equity55.53
P/B Ratio0.7
Op. Cash FlowCOP4065.1B
Free Cash FlowCOP325.5B
Industry P/E16.8

Technical Analysis

TrendBearish
RSI45.0
SupportCOP 38,560.00
ResistanceCOP 43,880.00
MA 20COP 40,888.00
MA 50COP 41,757.60
MA 200COP 42,282.00
MACDBullish
VolumeIncreasing
Fear & Greed Index91.75

Valuation

Fair ValueCOP 23,073.94
GradeOvervalued
TypeValue
Dividend Yield4.93%

Risk Assessment

Beta0.49
Volatility39.96%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.